You have 9 free searches left this month | for more free features.

alvocidib

Showing 26 - 50 of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in

Completed
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 7, 2013

B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • alvocidib
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jul 1, 2013

Solid Tumor Trial in New York (alvocidib, irinotecan HCl, fluorouracil)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • alvocidib
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 3, 2013

Liver Cancer Trial in New York (alvocidib, irinotecan HCl)

Completed
  • Liver Cancer
  • alvocidib
  • irinotecan hydrochloride
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 21, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • alvocidib
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Esophageal Cancer Trial in New York (alvocidib, paclitaxel)

Completed
  • Esophageal Cancer
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Solid Tumor Trial in New York (alvocidib, cisplatin, paclitaxel)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • alvocidib
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Breast Cancer Trial run by the NCI (alvocidib, docetaxel)

Completed
  • Breast Cancer
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 14, 2013

Gastrointestinal Stromal Tumor, Recurrent Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in New York

Completed
  • Gastrointestinal Stromal Tumor
  • +2 more
  • alvocidib
  • doxorubicin hydrochloride
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 18, 2013

Head Neck Cancer, Thromboembolism Trial run by the NCI (acetylsalicylic acid, alvocidib, clopidogrel bisulfate)

Completed
  • Head and Neck Cancer
  • Thromboembolism
  • acetylsalicylic acid
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jun 17, 2013

Solid Tumor Trial in New York (alvocidib, docetaxel)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
May 29, 2013

B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +42 more
  • alvocidib
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Solid Tumor Trial in Detroit (alvocidib, docetaxel)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 3, 2013

Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma

Completed
  • Recurrent Childhood Brain Stem Glioma
  • +21 more
  • alvocidib
  • pharmacological study
  • Arcadia, California
    COG Phase I Consortium
Jul 1, 2013

Solid Tumor Trial in Boston (alvocidib, gemcitabine HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • alvocidib
  • gemcitabine hydrochloride
  • Boston, Massachusetts
  • +1 more
Feb 27, 2013

Leukemia, Lymphocytic, Chronic Trial in Worldwide (alvocidib)

Completed
  • Leukemia, Lymphocytic, Chronic
  • alvocidib
  • San Diego, California
  • +33 more
Feb 8, 2013

Prostate Cancer Trial in United States (alvocidib)

Completed
  • Prostate Cancer
  • alvocidib
  • Duarte, California
  • +3 more
Feb 8, 2013

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Boston (biological, drug, other)

Terminated
  • HER2-positive Breast Cancer
  • +3 more
  • trastuzumab
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 31, 2013

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (alvocidib)

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • alvocidib
  • Rochester, Minnesota
    Mayo Clinic
Jan 15, 2013

Solid Tumor Trial in Albuquerque (alvocidib, gemcitabine HCl, irinotecan HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • alvocidib
  • +2 more
  • Albuquerque, New Mexico
    University of New Mexico
Jan 24, 2013

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +5 more
  • alvocidib
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 16, 2013

Lymphoma Trial in United States (alvocidib)

Completed
  • Lymphoma
  • alvocidib
  • Chicago, Illinois
  • +9 more
Feb 4, 2013

Endometrial Cancer Trial in Worldwide (alvocidib)

Completed
  • Endometrial Cancer
  • alvocidib
  • Birmingham, Alabama
  • +53 more
Jun 20, 2013

Kidney Cancer Trial in United States (alvocidib)

Completed
  • Kidney Cancer
  • alvocidib
  • Birmingham, Alabama
  • +100 more
Jun 20, 2013

Breast Cancer, Melanoma (Skin), Prostate Cancer Trial in Rochester (alvocidib, carboplatin, cisplatin)

Completed
  • Breast Cancer
  • +3 more
  • alvocidib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 2, 2011